Metraipolis › archive › dc_205e70ddf447

EGFR Status by Immunohistochemistry in Triple-Negative Breast Cancer: An Evaluation of Prevalence and Association with Clinical and Pathological Parameters — Europe PMC PMID:41099045

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41099045
DOI
10.30699/ijp.2025.2042447.3363
License (as archived)
solo-consultazione
Archived
2026-11-10T14:21:10.516Z
SHA-256 of the archived text
f616a15cb9460355fe72c725fa79f2523bd9e3d2902f2b5eea886a5104eef1e4
Stable URL of this page
https://metraipolis.com/documento/dc_205e70ddf447

How to cite

EGFR Status by Immunohistochemistry in Triple-Negative Breast Cancer: An Evaluation of Prevalence and Association with Clinical and Pathological Parameters — Europe PMC PMID:41099045 — Europe PMC (en), https://europepmc.org/article/MED/41099045 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_205e70ddf447 (Metraipolis archive dc_205e70ddf447, sha256 f616a15cb9460355fe72c725fa79f2523bd9e3d2902f2b5eea886a5104eef1e4)
BibTeX
@misc{dc205e70ddf447,
  title = {EGFR Status by Immunohistochemistry in Triple-Negative Breast Cancer: An Evaluation of Prevalence and Association with Clinical and Pathological Parameters — Europe PMC PMID:41099045},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41099045},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_205e70ddf447; sha256 f616a15cb9460355fe72c725fa79f2523bd9e3d2902f2b5eea886a5104eef1e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41099045. Agents can read the archived copy with the MCP tool read_document.